{"id":30982,"date":"2017-04-28T10:59:21","date_gmt":"2017-04-28T08:59:21","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=30982"},"modified":"2017-04-28T11:06:37","modified_gmt":"2017-04-28T09:06:37","slug":"novartis-multa-48-milioni-corea-del-sud","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/novartis-multa-48-milioni-corea-del-sud\/","title":{"rendered":"Novartis: fine of 48 million in South Korea"},"content":{"rendered":"<div>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignright\" src=\"http:\/\/www.zonasismica.sism.org\/wp-content\/uploads\/2015\/04\/ospedale.jpg\" alt=\"Risultati immagini per medico della corea del sud\" width=\"454\" height=\"341\" \/>Novartis was fined 48 million francs (<em>Swiss, \u20ac44.33 million, ed<\/em>) in South Korea for granting unauthorized discounts to doctors for prescribing his drugs.<\/p>\n<p>The Seoul Ministry of Health has also suspended for six months the insurance coverage of two preparations of the Swiss group, Exelon and Zometa.<\/p>\n<p>Contacted by the ats Novartis confirmed the announcement made by the Korean authorities and deplored the behavior of employees who did not comply with internal directives. Several employees of the group have been indicted in South Korea.<\/p>\n<\/div>\n<p><a href=\"https:\/\/www.tvsvizzera.it\/tvs\/novartis--multa-di-48-milioni-in-corea-del-sud\/43139452\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"color: #0000ff;\">SDA-ATS 27 APRIL 2017 \u2013 Swiss TV<\/span><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Novartis si \u00e8 vista infliggere una multa di 48 milioni di franchi (svizzeri, 44,33 milioni di \u20ac, n.d.r.) in Corea del Sud per aver garantito sconti non autorizzati ai medici affinch\u00e9 prescrivessero suoi farmaci. Il ministero della sanit\u00e0 di Seul ha anche sospeso per sei mesi la copertura assicurativa di due preparati del gruppo elvetico, &hellip;<\/p>","protected":false},"author":4,"featured_media":30983,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[22],"class_list":["post-30982","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-truffa-farmaci"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/30982","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=30982"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/30982\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/30983"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=30982"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=30982"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=30982"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}